Operating under a consent decree is a “dance with the devil,” but it is the last chance for dietary supplement manufacturers to stay in business if they fail to satisfy FDA about compliance with good manufacturing practices, according to food and drug attorney Tony Young.
At SupplySide West in Las Vegas on Nov. 7, Young advised supplement firms about responding after FDA notes GMP violations at manufacturing facilities and about adjusting to a consent decree...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?